INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.००
arrow_upward
+१.००%(+०.००९९) 1D
US$ १.०२
arrow_upward
+२.००% (+०.०२०)todayPre-market
Closed: अक्टोबर १९, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.०१
High
US$ १.०२
Low
US$ ०.९८
Mkt. cap
१०.३४ करोड
Avg. vol.
२८.७१ लाख
Volume
१.७८ हजार
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ १.०१
High
US$ १.०२
Low
US$ ०.९८
Mkt. cap
१०.३४ करोड
Avg. vol.
२८.७१ लाख
Volume
१.७८ हजार
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Simply Wall Street
·
३३ मिनेट पहिले
Why Is TTM Technologies (TTMI) Buying Ophir Optics For $650 Million?
TradingView
·
१ घण्टा पहिले
Asia’s Bitcoin Play Hits Wall Street: Metaplanet Set to Buy This Nasdaq-Listed Company for BTC Treasury Operations
MarketBeat
·
२६ मिनेट पहिले
Sonos, Inc. (NASDAQ:SONO) Stock Has Average Price Target of $20.00
Yahoo Finance
·
४९ मिनेट पहिले
US Stock Market Today: S&P 500 Futures Climb On Strong Factory And Earnings Hopes
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc